TrialLeukemia2024
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.
Guillermo Garcia-Manero et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it